End Taxpayer Subsidies for Prescription Drug Ads
This bill aims to stop companies from deducting the cost of direct-to-consumer prescription drug advertising from their taxes. This means pharmaceutical companies will no longer reduce their tax burden using these ad expenses, potentially influencing their marketing strategies and drug pricing.
Key points
Pharmaceutical companies will no longer be able to deduct direct-to-consumer prescription drug advertising expenses from their taxes.
This applies to ads in newspapers, radio, television, internet, and social media.
The goal is to end taxpayer funding of drug advertisements.
Expired
Citizen Poll